跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PALIPERIDONA TEVA 150 MG Y PALIPERIDONA TEVA 100 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
PALIPERIDONA TEVA 150 MG Y PALIPERIDONA TEVA 100 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG
Approved
STANDARD
PALIPERIDONA TEVA 150 MG Y PALIPERIDONA TEVA 100 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG
Teva B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 30, 2021
Approval ID
4681a1a12781d35b
Company
Teva B.V.
Type
Standard
Approval Details
Approval Id
4681a1a12781d35b
Drug Cima Aemps Name
PALIPERIDONA TEVA 150 MG Y PALIPERIDONA TEVA 100 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG
Register Number
86052
Holder Company Name
Teva B.V.
Marketing Company Name
Teva Pharma S.L.U.
Holder Company Detail Path
/organization/teva-pharma-b-v
Authorization Date
2021-11-30
Dosage Form
SUSPENSION INYECTABLE DE LIBERACION PROLONGADA
Dose
150 mg + 100 mg
Route Of Administration
VÍA INTRAMUSCULAR
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Teva B.V.
Company Detail Path
/organization/teva-pharma-b-v
Company Information
Pharmaceutical Company Name
Teva Pharma B.V.
Country Name
Netherlands
City Name
haarlem,noord-holland,country_nl
Address
Swensweg 5
Website
http://www.tevapharm.com
Active Ingredients
PALIPERIDONA PALMITATO
156 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 30, 2021
Approval ID
4681a1a12781d35b
Type
Standard
Back to CIMA-AEMPS Approvals